If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. Checkbox not checked

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).




schemaVersion:


SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D


 
CARRONADE CAPITAL MANAGEMENT, LP
 
Signature:/s/ Rinarisa Coronel DeFronze
Name/Title:Rinarisa Coronel DeFronze, Chief Compliance Officer & Counsel
Date:10/05/2026
 
Carronade Capital Master, LP
 
Signature:/s/ Rinarisa Coronel DeFronze
Name/Title:Rinarisa Coronel DeFronze, Authorized Signatory
Date:10/05/2026
 
CARRONADE CAPITAL GP, LLC
 
Signature:/s/ Rinarisa Coronel DeFronze
Name/Title:Rinarisa Coronel DeFronze, Authorized Signatory
Date:10/05/2026
 
CARRONADE CAPITAL MANAGEMENT GP, LLC
 
Signature:/s/ Rinarisa Coronel DeFronze
Name/Title:Rinarisa Coronel DeFronze, Authorized Signatory
Date:10/05/2026
 
GROPPER DAN
 
Signature:/s/ Dan Gropper
Name/Title:Individually
Date:10/05/2026

Exhibit 1

Transactions in the Shares Since the Filing of Amendment No. 3 to the Schedule 13D

Nature of

Transaction

Amount of Securities

Purchased / (Sold)

 

Price per Share ($)

Date of

Transaction

CARRONADE CAPITAL MANAGEMENT, LP
(Through the Managed Accounts)

Purchase of Common Stock 41,073 14.6575 08/10/2026
Purchase of Common Stock 96,695 14.8610 08/11/2026